Jie Lyu

Prof. Dr. Jie Lyu

College of Rehabilitation Sciences, Shanghai University of Medicine and Health Sciences, Shanghai, China
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JCJing Cheng
Jing Cheng
HJHai Jin
Hai Jin
XHXiaobei Hou
Xiaobei Hou
JLJie Lyu
Jie Lyu
XGXianfu Gao
Xianfu Gao
GZGuangyong Zheng
Guangyong Zheng

16 September 2013 in Applied Mathematics and Mechanics
Verified
Journal Article
Closed access
PDF file
JLJie Lyu
Jie Lyu
SXShi-Xiong Xu
Shi-Xiong Xu
WYWei Yao
Wei Yao
YZYu Zhou
Yu Zhou
QLQuan Long
Quan Long

3 September 2024 in Journal of Affective Disorders
Verified
Journal Article
Closed access
YYYu Yang
Yu Yang
KCKeren Cai
Keren Cai
JQJiale Qi
Jiale Qi
FWFuqiang Wang
Fuqiang Wang
RYRuoyu Yang
Ruoyu Yang
MCMing Cai
Ming Cai

4 October 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JLJie Lyu
Jie Lyu
JCJinfeng Cao
Jinfeng Cao
PZPeiming Zhang
Peiming Zhang
YLYang Liu
Yang Liu
HCHongtao Cheng
Hongtao Cheng
The processes governing tumor growth and angiogenesis are codependent. To study the relationship between them, we proposed a coupled hybrid continuum-discrete model. In this model, tumor cells, their microenvironment (extracellular matrixes, matrix-degrading enzymes, and tumor angiogenic factors), and their network of blood vessels, described by a series of discrete points, were considered. The results of numerical simulation reveal the process of tumor growth and the change in microenvironment from avascular to vascular stage, indicating that the network of blood vessels develops gradually as the tumor grows. Our findings also reveal that a tumor is divided into three regions: necrotic, semi-necrotic, and well-vascularized. The results agree well with the previous relevant studies and physiological facts, and this model represents a platform for further investigations of tumor therapy.

11 July 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
YYYu Yang
Yu Yang
JCJinfeng Cao
Jinfeng Cao
JLJie Lyu
Jie Lyu
Background: Cardiovascular disease (CVD) is a major global health issue. The triglyceride-glucose (TyG) index, a marker of insulin resistance, and the body roundness index (BRI), reflecting visceral adiposity, are key risk factors for chronic diseases. However, research on the long-term impact of changes in obesity and metabolic markers on CVD risk is limited. This study examines the association between long-term changes in the TyG-BRI composite index and CVD incidence in middle-aged and older Chinese adults.Methods: Data were obtained from the China Health and Retirement Longitudinal Study, which included 4,446 middle-aged and elderly from 2011 to 2015. The participants were classified into three clusters based on TyG-BRI changes by K-means clustering method. Logistic regression analyses and restricted cubic spline (RCS) regression analyses were used to assess the association between the TyG-BRI and CVD incidence. Receiver operating characteristic (ROC) curves were generated to compare the predictive accuracy of the TyG-BRI, TyG, and BRI.Results: By the end of 2015, 1,007 participants (22.6%) had developed CVD. The incidence of CVD increased progressively across TyG-BRI clusters. After adjusting for multiple covariates, logistic regression analysis revealed a significant correlation between the TyG-BRI and the onset of CVD [odds ratio, 95% confidence interval: 1.251 (1.139–1.373) per 1 SD increase]. The RCS regression analysis revealed a significant positive and linear relationship between the TyG-BRI and CVD incidence (P for overall < 0.001, P for nonlinear = 0.874). ROC analysis revealed that the TyG-BRI had greater predictive accuracy for CVD than either BRI or TyG alone did (AUC: 0.678 vs. 0.583 and 0.555, P < 0.001).Conclusion: Long-term variations in the TyG-BRI index are closely associated with CVD risk, demonstrating superior predictive performance compared to using BRI or TyG alone. Our findings offer new insights into the interplay between metabolic dysfunction and cardiovascular risk. TyG-BRI may serve as a more effective auxiliary tool for CVD risk assessment and provides valuable guidance for the early identification of high-risk populations.

12 April 2024 in Musculoskeletal Science and Practice
Verified
Journal Article
Closed access
XWXueying Wang
Xueying Wang
ZWZheng Wang
Zheng Wang
RARoger Adams
Roger Adams
CGCharlotte Ganderton
Charlotte Ganderton
JLJie Lyu
Jie Lyu
JHJia Han
Jia Han